Overview:
Retatrutide is a next-generation triple agonist (GLP-1, GIP, and glucagon receptor activity) used in advanced metabolic research. It supports appetite regulation, energy expenditure, and fat loss through multiple pathways.
This compound is often selected for high-efficiency protocols and advanced users.
Triple Action Metabolic Support * Appetite Regulation * Advanced Fat Loss
Common vial sizes:
10 mg
20 mg
30 mg
60 mg
What It Supports/ Who It’s Best For
What It Supports
Appetite suppression
Increased energy expenditure
Enhanced fat loss
Advanced metabolic support
Experienced GLP-1 users
Individuals seeking maximum fat loss support
Those transitioning from Tirzepatide
Advanced protocols